First Manhattan CO Theravance Biopharma, Inc. Transaction History

First Manhattan CO

$31.9 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$8.22 - $11.59 $0 - $0	0 New	0 $0
Q4 2023 Feb 13, 2024	BUY	$8.58 - $11.4 $0 - $0	0 New	0 $0
Q3 2023 Nov 14, 2023	BUY	$8.38 - $10.44 $0 - $0	0 New	0 $0
Q2 2023 Aug 14, 2023	BUY	$10.16 - $11.92 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$9.87 - $11.44 $0 - $0	0 New	0 $0
Q4 2022 Feb 14, 2023	BUY	$9.65 - $11.34 $0 - $0	0 New	0 $0
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $0 - $0	0 New	0 $0
Q2 2022 Aug 15, 2022	BUY	$8.41 - $10.34 $0 - $0	0 New	0 $0
Q1 2022 May 16, 2022	BUY	$8.33 - $12.96 $0 - $0	0 New	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.42 - $11.05 $0 - $0	0 New	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $0 - $0	0 New	0 $0
Q2 2021 Aug 16, 2021	BUY	$14.52 - $22.46 $0 - $0	0 New	0 $0
Q1 2021 May 14, 2021	BUY	$16.57 - $21.08 $0 - $0	0 New	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.89 - $20.16 $0 - $0	0 New	0 $0
Q3 2020 Nov 12, 2020	BUY	$14.79 - $22.49 $0 - $0	0 New	0 $0
Q2 2020 Aug 14, 2020	BUY	$20.64 - $30.69 $0 - $0	0 New	0 $0
Q4 2018 Jan 30, 2019	SELL	$22.52 - $35.07 $0 - $0	0 Closed	0 $0
Q3 2018 Oct 15, 2018	SELL	$22.83 - $32.67 $14.1 Million - $20.2 Million	-619,085 Closed	0 $0
Q2 2018 Aug 01, 2018	SELL	$22.06 - $25.52 $469,216 - $542,810	-21,270 Reduced 3.32%	619,085 $14 Million
Q1 2018 Apr 20, 2018	SELL	$23.37 - $29.71 $19 Million - $24.2 Million	-813,812 Reduced 55.96%	640,355 $15.5 Million
Q4 2017 Jan 22, 2018	SELL	$25.82 - $35.66 $4.11 Million - $5.67 Million	-159,000 Reduced 9.86%	1,454,167 $40.6 Million
Q3 2017 Oct 25, 2017	BUY	$23.88 - $34.96 $38.5 Million - $56.4 Million	1,613,167	1,613,167 $55.2 Million

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

Madison Avenue Partners, LP New York, NY

9.51M
Shares

$91.2 Million
9.44% of portfolio
Weiss Asset Management LP Boston, MA

7.46M
Shares

$71.5 Million
1.94% of portfolio
Newtyn Management, LLC New York, NY

4.5M
Shares

$43.1 Million
6.4% of portfolio
Black Rock Inc. New York, NY

3.78M
Shares

$36.3 Million
0.0% of portfolio
Irenic Capital Management LP New York, NY

2.76M
Shares

$26.5 Million
1.95% of portfolio

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Account